Latest content
- 1403/10/15 The 5th Convergence Congress on Endocrine Sciences: Innovations in Disease Diagnosis and Treatment
- 1403/10/15 Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East 1990 2019 findings from the Global Burden of Disease study 2019
- 1403/10/12 A Comprehensive Student Health Study at Tehran University of Medical Sciences: Lifestyle Changes and Their Impact on Health and Academic Performance
- 1403/10/12 A decision rule algorithm for the detection of patients with hypertension using claims data
- 1403/10/12 Global regional and national burden and quality of care index (QCI) of oral disorders a systematic analysis of the global burden of disease study 1990-2017
- 1403/10/12 Non-communicable diseases risk factors in Iran a review of the present status and action plans
- 1403/10/11 WHO Recognizes Endocrinology and Metabolism Institute as Collaborating Centre
* Noncommunicable disease facility-based monitoring guidance *
In late 2022, WHO developed the Noncommunicable disease facility-based monitoring guidance for NCD patient and program monitoring, including a framework and parsimonious set of relevant, valid, and feasible standardized indicators to guide recording and reporting of health services data at the primary care level.
Countries can use this framework to strengthen monitoring for NCDs by leveraging existing national health information systems, particularly routine health facility reporting systems and health facility survey systems
.
Non-Communicable Diseases Research Center
Endocrinology and Metabolism Research Institute
- Phone : 02188631293
- Fax : 02188631295
- Postal code : 1411713119
- email: ncdrc_emri@sina.tums.ac.ir
